Substituted dabigatran compounds (I) are new. Substituted dabigatran compounds of formula (I) and their derivatives, salts, solvates, or the solvates of salts are new. R1 : H or optionally branched, optionally saturated and optionally substituted 1-12C-hydrocarbon chain; and n : 1-10. Independent claims are included for: (1) a drug comprising (I) in combination with one or more further active agents; and (2) the preparation of (I). [Image] ACTIVITY : Hemostatic; Thrombolytic; Cerebroprotective; Vasotropic; Cardiant; Antiarrhythmic; Cytostatic. MECHANISM OF ACTION : Serine protease inhibitor.本発明は、ダビガトランのプロドラッグ誘導体、疾患、とくに血栓性疾患、発作、心筋梗塞および/または心房細動および心不整脈ならびにあらゆる病因の腫瘍性疾患の処置および/または予防におけるそれらの使用に関する。